Curtis Brown carries business cards with old pictures of his tumors, including an egg-sized growth on his neck. He says they were each shed after the application of a flesh-eating paste containing the medicinal herb bloodroot.
"I cured myself of cancer," the cards read.
Georgia's medical board and the US Food and Drug Administration do not share Brown's enthusiasm for the paste.
The state board has accused its maker, Dan Raber, a rural pastor-turned-healer, of practicing medicine without a license. FDA agents recently raided Raber's business, and a doctor could lose her medical license for allegedly knowing Raber was giving people the paste -- not approved for the treatment of cancer -- and not reporting him.
Raber's paste is described by the medical board as "a caustic, tissue-destroying substance that eats away human skin and flesh." On his Web site, Raber claims the remedy helped him remove a tumor on his wrist, and he displays graphic before-and-after photos of others who have used the paste, including women with scabs on their breasts and men with scarred faces.
While the state board has leveled serious allegations against Raber, he has not been charged with a crime. Prosecutors are studying the case.
Raber has never responded publicly to the board's allegations. In an interview, his son, Kelly, defended his father and his products, which also include enzyme capsules they claim will destroy cancerous cells.
"The herb does not kill healthy tissue," Kelly Raber said, smearing some of the paste on his nose. "Instead, it performs a process known as apoptosis that allows the [cancer] cells to self-destruct."
He said his father's paste is being singled out because it is an old remedy that cannot be patented and therefore would not generate large profits for the medical establishment or giant pharmaceutical companies.
Dan Raber was named in a state complaint filed against Dr. Lois March, an ear, nose and throat specialist in south Georgia who risks losing her medical license for allegedly providing pain medication to 12 patients who had received Raber's bloodroot treatments. The board said seven of the patients had breast cancer and that the doctor knew or should have known that Raber's use of bloodroot "mutilated their breasts and caused excruciating pain."
"These are wild accusations that aren't true," March said.
During a 2003 crackdown on alternative medicine merchants who made false claims on the Internet, the FDA shut down a Louisiana company that sold a bloodroot paste and its owner was sent to prison.
To prove bloodroot's effectiveness, Raber cites numerous books and studies that support the use of salves and pastes containing herbs and other ingredients for treating skin cancer. Such preparations are supposed to isolate the tumor from healthy tissue and cause it to fall out. Mark Blumenthal, executive director of the American Botanical Council, said bloodroot has been used for years by nontraditional healers to treat skin cancers, but he acknowledged "the efficacy has been unproven from a scientific point of view."
After years of sun exposure, Brown, the retired farmer was plagued with skin cancer. Doctors surgically removed cancerous growths from his face and arms, but when a nearly 8cm-long tumor grew on the left side of his neck in 2002, Brown instead tried the paste, even though it meant nearly a month of excruciating pain. He said after 26 days of using the paste his tumor fell off, leaving a crater in his neck that eventually healed. A scar is hardly noticeable just below his jaw.
Michael Bradley of Monroe, Georgia, a Vietnam veteran who said he was exposed to the herbicide Agent Orange, said he decided to try Raber's paste after doctors confirmed he had a large melanoma on his upper back.
"It came out after 30 days," Bradley said. "It was very painful, but I'm still alive. I know a lot of people who didn't go that route and they're dead."
Four people jailed in the landmark Hong Kong national security trial of "47 democrats" accused of conspiracy to commit subversion were freed today after more than four years behind bars, the second group to be released in a month. Among those freed was long-time political and LGBTQ activist Jimmy Sham (岑子杰), who also led one of Hong Kong’s largest pro-democracy groups, the Civil Human Rights Front, which disbanded in 2021. "Let me spend some time with my family," Sham said after arriving at his home in the Kowloon district of Jordan. "I don’t know how to plan ahead because, to me, it feels
Poland is set to hold a presidential runoff election today between two candidates offering starkly different visions for the country’s future. The winner would succeed Polish President Andrzej Duda, a conservative who is finishing his second and final term. The outcome would determine whether Poland embraces a nationalist populist trajectory or pivots more fully toward liberal, pro-European policies. An exit poll by Ipsos would be released when polls close today at 9pm local time, with a margin of error of plus or minus 2 percentage points. Final results are expected tomorrow. Whoever wins can be expected to either help or hinder the
North Korea has detained another official over last week’s failed launch of a warship, which damaged the naval destroyer, state media reported yesterday. Pyongyang announced “a serious accident” at Wednesday last week’s launch ceremony, which crushed sections of the bottom of the new destroyer. North Korean leader Kim Jong-un called the mishap a “criminal act caused by absolute carelessness.” Ri Hyong-son, vice department director of the Munitions Industry Department of the Party Central Committee, was summoned and detained on Sunday, the Korean Central News Agency (KCNA) reported. He was “greatly responsible for the occurrence of the serious accident,” it said. Ri is the fourth person
SKEPTICAL: Given the challenges, which include waste disposal and potential domestic opposition, experts warn that the 2032 nuclear timeline is overambitious Indonesia is hoping going nuclear can help it meet soaring energy demand while taming emissions, but faces serious challenges to its goal of a first small modular reactor by 2032. Its first experiment with nuclear energy dates to February 1965, when then-Indonesian president Sukarno inaugurated a test reactor. Sixty years later, Southeast Asia’s largest economy has three research reactors, but no nuclear power plants for electricity. Abundant reserves of polluting coal have so far met the enormous archipelago’s energy needs, but “nuclear will be necessary to constrain the rise of and eventually reduce emissions,” said Philip Andrews-Speed, a senior research fellow at the
RSS